NEWARK, DE —The global dialysis equipment market is valued at USD 11.66 billion in 2025 and is projected to reach USD 18.63 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.8% during the forecast period. This steady growth is largely propelled by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), together with an aging global population and increasing incidence of diabetes and hypertension — the primary risk factors for kidney failure. Advancements in portable, home-based, and smart-connected dialysis technologies are further improving patient access, convenience, and treatment personalization, positioning the dialysis equipment market for continued expansion.

Read Full Report- https://www.futuremarketinsights.com/reports/dialysis-equipment-market

Market snapshot: global market 2025–2035

• Market size 2025? USD 11.66 billion
• Market size 2035? USD 18.63 billion
• CAGR? 4.8%
• Leading product segment(s) and shares: Haemodialysis devices – 60.3% value share in 2025
• Leading disease condition and share: Chronic kidney disease (CKD) – 70.5% value share in 2025
• Leading end use and growth: Home care settings – fastest CAGR of 6.5% from 2025 to 2035
• Key growth regions: North America, Western Europe, East Asia (particularly strong performance in USA, Japan, Germany)
• Top companies: Baxter, Asahi Kasei Corporation, Fresenius Medical Care AG & Co. KGaA, Cantel Medical, B. Braun Melsungen AG, NIPRO, JMS Co. Ltd., Rockwell Medical, Teleflex Incorporated, Quanta, Outset Medical, Inc., HEMOCLEAN CO., LTD.

Market Momentum (YoY Path)

The dialysis equipment market begins 2025 at USD 11.66 billion and is expected to reach approximately USD 13.0–13.4 billion by 2028 as smart home hemodialysis and automated peritoneal dialysis systems gain wider clinical acceptance. By 2030 the market is projected to surpass USD 14.5 billion, supported by growing reimbursement support for home dialysis and increasing CKD/ESRD patient volumes. Momentum continues into 2031 (~USD 15.2–15.5 billion), accelerates toward USD 16.8–17.0 billion in 2033, and ultimately achieves the forecasted USD 18.63 billion valuation by the close of 2035, reflecting the sustained shift toward patient-centric and technology-enabled renal care solutions.

Why the Market is Growing

The dialysis equipment market is expanding primarily due to the increasing prevalence of chronic kidney diseases (CKD) and the rising number of patients requiring dialysis treatment. The growing aging population, combined with the rising incidence of diabetes and hypertension — major risk factors for CKD — is significantly driving demand. Advancements in dialysis technologies, particularly portable and home dialysis systems, are expanding treatment options, improving patient convenience, and fueling broader adoption. The integration of remote monitoring, telehealth capabilities, and AI-driven features is further shifting the market toward personalized, patient-centric care.

Segment Spotlight

Product Type

Haemodialysis devices remain the backbone of the dialysis equipment market, commanding a 60.3% value share in 2025. Their dominance stems from widespread clinical adoption for managing end-stage renal disease (ESRD) and chronic kidney disease (CKD), efficient toxin and fluid removal, cost-effectiveness compared to transplantation or peritoneal alternatives, and continuous improvements in membrane technology, biocompatible materials, and automated monitoring systems that enhance safety and comfort.

Disease

Condition Chronic kidney disease (CKD) leads the dialysis equipment market with a 70.5% value share in 2025. The segment’s strength is driven by CKD’s progressive nature, strong association with diabetes and hypertension, expanding elderly population, and the persistent, long-term dialysis requirement — unlike short-term acute cases — which sustains consistent demand across hospitals, clinics, and home care settings.

End Use

Home care settings represent the fastest-growing end-use category in the dialysis equipment market, projected to expand at a 6.5% CAGR from 2025 to 2035. Rising patient preference for comfort, flexibility, and independence — especially among elderly and mobility-limited individuals — combined with device miniaturization, automation, remote monitoring, and supportive reimbursement policies in key regions, is accelerating the shift toward home-based peritoneal and hemodialysis therapies.

Drivers, Opportunities, Trends, Challenges

Drivers

The dialysis equipment market is propelled by the rapidly aging global population, which increases the prevalence of CKD and ESRD and heightens demand for advanced dialysis solutions. The growing burden of end-stage renal disease, driven by diabetes, hypertension, obesity, and lifestyle factors, further intensifies the need for reliable equipment. Heightened public and clinical awareness of kidney health — reinforced by global campaigns such as World Kidney Day — promotes early detection, risk-factor management, and timely dialysis intervention.

Opportunities

Stringent yet evolving regulatory frameworks (FDA, EU MDR, CDSCO) are pushing manufacturers toward safer, smarter, and more connected devices, creating openings for innovation in portable, wearable, and telehealth-enabled systems. The accelerating shift to home dialysis, supported by reimbursement incentives and infrastructure relief goals in developed markets, opens significant growth potential for compact, user-friendly technologies.

Trends

 Leading manufacturers are embedding remote monitoring, AI analytics, cloud connectivity, and automation into dialysis systems — evident in platforms such as NxStage Versi HD, HomeChoice Claria with Sharesource, Tablo, SC+, and RxT 21. The market shows semi-annual acceleration in certain periods (e.g., H1 2025–2035 at 5.9%), reflecting faster uptake of home-based and smart solutions.

Challenges

 High manufacturing complexity, precision engineering, expensive durable components, prolonged regulatory validation (FDA 510(k), PMA, EU MDR), and ongoing maintenance requirements drive elevated costs that limit accessibility — especially in low- and middle-income countries — and create inequalities in life-saving dialysis treatment.

Competitive Landscape

The dialysis equipment market remains competitive with Tier 1 companies (Baxter, Asahi Kasei Corporation, Fresenius Medical Care AG & Co. KGaA, Cantel Medical) holding 54.4% share through heavy R&D investment, global expansion, and strategic partnerships/acquisitions. Tier 2 players (Rockwell Medical, JMS Co. Ltd., Teleflex Incorporated, B. Braun Melsungen AG, NIPRO) capture 6.1% with strong regional and niche presence, while Tier 3 innovators (Quanta, Outset Medical, HEMOCLEAN CO., LTD.) contribute specialized, high-performance solutions. Recent moves include Asahi Kasei’s acquisition of Calliditas Therapeutics (May 2024), Baxter’s Vantive renal spinoff announcement (July 2023), and B. Braun’s Nephtec GmbH integration (November 2021).

Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates: https://www.futuremarketinsights.com/reports/brochure/rep-gb-711                   

Request for Sample Report | Customize Report |purchase Full Report -https://www.futuremarketinsights.com/reports/sample/rep-gb-711

Scope of the Report

• Quantitative units: Value in USD billion, CAGR percentages
• Segmentation: Product (haemodialysis devices, peritoneal dialysis devices, continuous renal replacement therapy), Disease Condition (chronic, acute), End Use (hospitals, clinics, ambulatory surgical centres, home care settings)
• Regions: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, Middle East & Africa
• Countries: United States, United Kingdom, Germany, France, Japan (among others covered)
• Key companies profiled: Baxter, Asahi Kasei Corporation, Fresenius Medical Care AG & Co. KGaA, Cantel Medical, Rockwell Medical, JMS Co. Ltd., Teleflex Incorporated, B. Braun Melsungen AG, NIPRO, HEMOCLEAN CO., LTD., Quanta, Outset Medical, Inc.

FAQ

What is the current size of the dialysis equipment market? The global dialysis equipment market is valued at USD 11.66 billion in 2025.

What will be the size of the dialysis equipment market by 2035? The market is projected to reach USD 18.63 billion by 2035.

What is the expected CAGR for the dialysis equipment market? The market is anticipated to grow at a 4.8% CAGR from 2025 to 2035.

Which product segment holds the largest share? Haemodialysis devices command 60.3% of the value share in 2025.

Which disease condition drives the majority of demand? Chronic kidney disease (CKD) accounts for 70.5% of the value share in 2025.

Which end-use segment is growing the fastest? Home care settings are projected to register the highest CAGR of 6.5% during 2025–2035.

Explore More Related Studies Published by FMI Research:

Non-Insulin Peptide Drugs Market- https://www.futuremarketinsights.com/reports/non-insulin-peptide-drugs-market

Viral Safety Testing Market- https://www.futuremarketinsights.com/reports/viral-safety-testing-market

Intracameral Antibiotics Market- https://www.futuremarketinsights.com/reports/intracameral-antibiotics-market

MRI-based Quantitative Biomarkers Market- https://www.futuremarketinsights.com/reports/mri-based-quantitative-biomarkers-market

Unattended Fundus Camera Market- https://www.futuremarketinsights.com/reports/unattended-fundus-camera-market

About Future Market Insights (FMI)

 Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why FMI: Decisions that Change Outcomes- https://www.futuremarketinsights.com/why-fmi

Contact Us:    

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Have a specific Requirements and Need Assistant on Report Pricing or Limited Budget please contact us - sales@futuremarketinsights.com